AR016514A1 - COMPOSITION TO IMPROVE STOMACH DISEASE, METHOD TO PREPARE SUCH COMPOSITION AND METHOD TO USE IT - Google Patents

COMPOSITION TO IMPROVE STOMACH DISEASE, METHOD TO PREPARE SUCH COMPOSITION AND METHOD TO USE IT

Info

Publication number
AR016514A1
AR016514A1 ARP980103405A ARP980103405A AR016514A1 AR 016514 A1 AR016514 A1 AR 016514A1 AR P980103405 A ARP980103405 A AR P980103405A AR P980103405 A ARP980103405 A AR P980103405A AR 016514 A1 AR016514 A1 AR 016514A1
Authority
AR
Argentina
Prior art keywords
composition
papaya
prepare
stomach disease
chymopapain
Prior art date
Application number
ARP980103405A
Other languages
Spanish (es)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of AR016514A1 publication Critical patent/AR016514A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22002—Papain (3.4.22.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Una composicion que comprende: 1) una o más composiciones que reducen la acidez estomacal; y 2) una composicion extraída de la papaya, preferentemente quecomprende una o más enzimas proteolíticas, que incluya pero que no esté limitada a, la papaina,quimopapaina y proteinasa III de papaya. La presentecomposicion puede utilizarse para proveer un alivio mejorado, conveniente al malestar gástrico que resulta de la secrecion excesiva de ácido gástrico. Unmétodo para preparar una composicion que comprende: 1) una o más composiciones que reducen la acidez estomacal y 2) una composicion extraída de la papaya, quecomprende preferentemente una o más enzimas proteolíticas, que incluye pero que no se encuentra limitada a, la papaina, quimopapaina y proteinasa III de papayay un método para utilizar dicha composicion.A composition comprising: 1) one or more compositions that reduce heartburn; and 2) a composition extracted from papaya, preferably comprising one or more proteolytic enzymes, including but not limited to, papain, chymopapain and papaya proteinase III. The present composition can be used to provide improved, convenient relief of gastric discomfort resulting from excessive gastric acid secretion. A method for preparing a composition comprising: 1) one or more compositions that reduce heartburn and 2) a composition extracted from papaya, which preferably comprises one or more proteolytic enzymes, which includes but is not limited to, papain, Papay chymopapain and proteinase III a method of using said composition.

ARP980103405A 1997-07-15 1998-07-14 COMPOSITION TO IMPROVE STOMACH DISEASE, METHOD TO PREPARE SUCH COMPOSITION AND METHOD TO USE IT AR016514A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5254397P 1997-07-15 1997-07-15

Publications (1)

Publication Number Publication Date
AR016514A1 true AR016514A1 (en) 2001-07-25

Family

ID=21978305

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103405A AR016514A1 (en) 1997-07-15 1998-07-14 COMPOSITION TO IMPROVE STOMACH DISEASE, METHOD TO PREPARE SUCH COMPOSITION AND METHOD TO USE IT

Country Status (9)

Country Link
EP (1) EP1001796A1 (en)
JP (1) JP2002509539A (en)
AR (1) AR016514A1 (en)
AU (1) AU8296898A (en)
BR (1) BR9809419A (en)
CA (1) CA2286357A1 (en)
PE (1) PE102699A1 (en)
WO (1) WO1999003486A1 (en)
ZA (1) ZA986247B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000083619A (en) * 1998-07-15 2000-03-28 Oju Seiyaku:Kk Health food and its preparation
BRPI0006503B1 (en) * 2000-02-04 2017-05-09 Biolab Sanus Farmacêutica Ltda gel, cream, aerosol, spray, liquid and lyophilized composition of papain-based carrier
WO2007010547A1 (en) * 2004-11-04 2007-01-25 Abhoy Sankar Arora A phyto-medicine and a process for the preparation thereof
GB0820846D0 (en) * 2008-11-14 2008-12-24 Carson John W Improved proteinaceous digestates
IT201700090582A1 (en) * 2017-08-04 2019-02-04 Neilos S R L Composition for use in the prevention and / or treatment of gastric or gastroesophageal disorders.

Also Published As

Publication number Publication date
ZA986247B (en) 1999-02-05
WO1999003486A1 (en) 1999-01-28
AU8296898A (en) 1999-02-10
PE102699A1 (en) 1999-11-05
JP2002509539A (en) 2002-03-26
BR9809419A (en) 2000-06-13
CA2286357A1 (en) 1999-01-28
EP1001796A1 (en) 2000-05-24

Similar Documents

Publication Publication Date Title
DE69531457D1 (en) Sulfonamide
CO4970765A1 (en) LOW PH COMPOSITIONS CONTAINING ACID FOR PERSONAL CARE THAT EXHIBIT REDUCED ITCHING
DE69932864D1 (en) New fatty acid analogues for the treatment of hypertension
DE69203345T2 (en) NEW PROTEASES.
IL151313A0 (en) Lipase containing pharmaceutical compositions
HUP0300299A2 (en) Composition comprising free amino acids
AR053946A2 (en) ORIGINAL BACILLUS STEAROTHERMOPHILUS ALFA-AMYLASE VARIANT
NZ335981A (en) Ketobenzamides as calpain inhibitors
BR9811099A (en) Urokinase inhibitors
BG103096A (en) Thrombin inhibitors
HK1025511A1 (en) Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
HUP0001014A2 (en) Use of gastrointestinal lipase inhibitors
DK0688226T3 (en) Protein preparation for the prevention and therapy of periodontitis or other bacterial pathologies in the oral cavity
ES2143666T3 (en) P-AMIDINOBENCILAMIDES DIPEPTIDICAS WITH REMAINS SULFONILO, OR AMINOSULFONILO N-TERMINALES.
YU95302A (en) Stable gabapentin having ph within a controlled range
AR016514A1 (en) COMPOSITION TO IMPROVE STOMACH DISEASE, METHOD TO PREPARE SUCH COMPOSITION AND METHOD TO USE IT
NO983103L (en) New monofunctional EDTA, DTPA and TTHA derivatives and their use in medical diagnostics and therapy
AP2002002651A0 (en) Sodium-hydrogen exchanger type 1 inhibitor (nhe-1)
MY128306A (en) Oct formulations
AU6722498A (en) Disubstituted biphenyloxazolines
WO2002081665A3 (en) Implantation serine proteinases
ATE290878T1 (en) INHIBITION OF INVASIVE REMODULATION
AU3282700A (en) Solution for injection for the treatment of arthroses
UA10455A (en) Composition for field treatment
MD1218F1 (en) Antimutagenic agent